{"title": "The opioid epidemic: is pharma doing enough to develop treatments for the crisis?", "author": null, "url": "https://psychiatry.uw.edu/who-we-are/news-events/news/the-opioid-epidemic-is-pharma-doing-enough-to-develop-treatments-for-the-crisis/", "hostname": "psychiatry.uw.edu", "description": null, "sitename": "psychiatry.uw.edu", "date": "2023-01-01", "cleaned_text": "Even with academic collaborations, private players are lagging behind public institutions in finding new treatments for opioid addiction. [Marco Pravetoni, PhD](https://psychiatry.uw.edu/profile/marco-pravetoni/), is currently working on developing a potential vaccine aimed at oxycodone, which is in Phase I trials, and aims to get vaccines targeting other drugs like fentanyl or heroin into the clinic in the coming years. The opioid epidemic: is pharma doing enough to develop treatments for the crisis? Pharmaceutical Technology | May 30, 2022 Even with academic collaborations, private players are lagging behind public institutions in finding new treatments for opioid addiction. "}